MedPath

Anti-vascular endothelial growth factor therapy for ocular diseases of neovascularizatio

Not Applicable
Conditions
retinopathy of prematurity neovascular glaucome vasoproliferative tumor choroidal neovascularization
Registration Number
JPRN-UMIN000027243
Lead Sponsor
School of Medicine Toho University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1, high risk of stroke infarction 2, high risk of myocardial infarction 3, ocular infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of ocular blood flow at 1 week, 1 months and 3 months from the initial treatment.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath